Medication switch
semaglutide → tirzepatide — re-titration required
Type 2 diabetes patients switching from semaglutide to tirzepatide for stronger glycemic control.
Medically reviewed by Dr. Jane Novak, MD, MPH on May 15, 2026
Cross-ingredient switch — re-titration required
Ozempic uses semaglutide; Mounjaro uses tirzepatide. You restart from the starter dose and re-titrate over 12–20 weeks to reduce GI side effects.
These medications use different active ingredients (semaglutide vs. tirzepatide). Re-titration from the starter dose is required to reduce GI side effects.
Start at Mounjaro 2.5 mg (the standard starter dose) for 4 weeks, then escalate every 4 weeks: 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg. Most patients stabilize at 5 mg or 10 mg. Full titration from Ozempic 2 mg to Mounjaro 10 mg typically takes 16-20 weeks.
GI side effects (nausea, diarrhea) usually return temporarily during re-titration even though both drugs have similar mechanisms. The 4-week dose-escalation cadence is specifically designed to minimize this.
Mounjaro PA criteria require type 2 diabetes diagnosis. Some insurers require step-through documentation showing inadequate response to GLP-1 alone before approving GIP/GLP-1 dual agonist.
Our ranked telehealth providers handle switching prescriptions, prior authorizations, and pharmacy coordination — typically 1–3 business days end to end.
See top providersEditorial ranking is independent of commission rates.
In the SURPASS-2 head-to-head trial, tirzepatide 15 mg achieved greater A1C reduction (-2.3%) compared to semaglutide 1 mg (-1.9%). Tirzepatide also produced more weight loss. Real-world differences depend on individual response.
Reverse direction
Mounjaro → Ozempic
Other from Ozempic
Ozempic → Wegovy
Other from Ozempic
Ozempic → Zepbound
Other to Mounjaro
Zepbound → Mounjaro
Other to Mounjaro
Wegovy → Mounjaro
Resources for patients moving from Ozempic to Mounjaro.
Drug overview
FDA-label overview of Mounjaro (tirzepatide) with dosing schedule and contraindications.
ReadDrug overview
What you're switching from. Pricing, indications, and patient experience.
ReadLive data
Check current Mounjaro availability and which doses are limited.
ReadFree tool
Decision tree based on FDA criteria. Flags contraindications.
ReadFree tool
Draft a payer-ready PA letter your prescriber can sign in minutes.
ReadRanked & reviewed
Telehealth providers ranked by price, ratings, and insurance.
Read